FcγRIIA alleles are heritable risk factors for lupus nephritis in African Americans

Journal of Clinical Investigation

Volumn 97, Issue 5, 1996, Pages 1348-1354

  Salmon, Jane E ^a,b   Millard, Sean ^a,b   Schachter, Leah A ^a,b   Arnett, Frank C ^c   Ginzler, Ellen M ^d   Gourley, Mark F ^e   Ramsey Goldman, Rosalind ^f   Peterson, Margaret G E ^a,b   Kimberly, Robert P ^a,b  

^a HOSPITAL FOR SPECIAL SURGERY   (United States)

^b WEILL CORNELL MEDICAL COLLEGE   (United States)

^c UNIVERSITY OF TEXAS   (United States)

^d SUNY DOWNSTATE MEDICAL CENTER   (United States)

^e NATIONAL INSTITUTES OF HEALTH   (United States)

^f NORTHWESTERN UNIVERSITY   (United States)

Author keywords

Fc receptors; immunoglobulin; nephritis; phagocytes; systemic lupus erythematosus

Indexed keywords

FC RECEPTOR;

ALLELE; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; GENETIC RISK; GENETIC SUSCEPTIBILITY; HUMAN; HUMAN CELL; LUPUS ERYTHEMATOSUS NEPHRITIS; NEGRO; PRIORITY JOURNAL; SYSTEMIC LUPUS ERYTHEMATOSUS;

EID: 0029866721     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI118552     Document Type: Article

References (49)

1. Cochrane, C.G., and D. Koeffler. 1973 Immune complex disease in experimental animals and man. Adv. Immunol 16:185-253.
2. Frank, M.M., M.I. Hamburger, T.J. Lawley, R.P. Kimberly, and P.H. Plotz. 1979. Detective reticuloendothelial system Fc-receptor function in systemic lupus erythematosus N Engl. J. Med. 300:518-523.
3. Parris, T.M , R.P. Kimberly, R.D. Inman, J.S. McDougal, A. Gibofsky, and C.L Christian 1982. Defective Fc receptor-mediated function of the mononuclear phagocyte system in lupus nephritis. Ann. Intern. Med. 97:526-532.
4. Kimberly, R.P., T.M. Parris, R.D. Inman, and J.S. McDougal. 1983. Dynamics of mononuclear phagocyte system Fc receptor function in systemic lupus erythematosus. Relation to disease activity and circulating immune complexes. Clin Exp. Immunol. 51:261-268.
5. Hamburger, M.I., T J. Lawley, R.P. Kimberly, P.H. Plotz, and M.M. Frank. 1982. A serial study of splenic reticuloendothelial system Fc receptor functional activity in systemic lupus erythematosus Arthritis & Rheum. 25:48-54.
6. Kimberly, R.P., A. Gibofsky, J.E Salmon, and M. Fotino. 1983. Impaired Fc-mediated mononuclear phagocyte system clearance in HLA-DR2 and MT1-positive healthy young adults J. Exp Med 157:1698-1703
7. Salmon, J E , R.P. Kimberly, A. Gibofsky, and M. Fotino. 1984. Defective mononuclear phagocyte function in systemic lupus erythematosus: dissociation of Fc receptor-ligand binding and internalization. J Immunol. 133:2525-2531.
8. Ravetch, J.V., and J.P. Kinet. 1991. Fc receptors. Annu. Rev. Immunol. 9: 457-492.
9. Schreiber, A.D . M.D. Rossman, and A.I. Levinson. 1992 The immunobiology of human Fcγ receptors on hematopoietic cells and tissue macrophages. Clin. Immunol. Immunopathol. 62:S66-S72.
10. van de Winkel, J.G.J., and P J.A. Capel. 1993 Human IgG Fc receptor heterogeneity. molecular aspects clinical implications. Immunol. Today. 14: 215-221.
11. Hulett, M.D , and P.M. Hogarth. 1994. Molecular Basis of Fc receptor function Adv. Immunol 57Z.1-127.
12. Salmon, J.E., J.C. Edberg, and R.P. Kimberly. 1990. Fcγ receptor III on human neutrophils Allelic variants have functionally distinct capacities. J. Clin. Invest. 85:1287-1295.
13. Salmon, J E., J.C. Edberg, N L Brogle, and R.P. Kimberly. 1992. Allelic polymorphism of human Fcγ receptor IIA and Fcγ receptor IIIB. Independent mechanisms for differences in human phagocyte function. J. Clin. Invest. 89: 1274-1281.
14. Warmerdam, P.A.M., J.G.J van de Winkel, E.J. Gosselin, and P.J.A Capel. 1990. Molecular basis for a polymorphism of human Fcγ receptor II (CD32). J. Exp. Med. 172:19-25.
15. Warmerdam, P.A.M., J.G.J. van de Winkel, A. Vlug, N.A C. Westerdal, and P.J.A. Capel. 1991. A single amino acid in the second Ig-like domain of the human Fcγ receptor II is critical for human IgG2 binding. J. Immunol. 147: 1338-1343.
16. Clark, M.R., S.G. Stuart, R.P. Kimberly, P.A. Ory, and I.M. Goldstein. 1991. A single ammo acid distinguishes the high-responder from low-responder form of Fc receptor II on human monocytes. Eur. J Immunol. 21:1911-1916
17. Tate, B.J., E. Witort. I F C. McKenzie, and P.M. Hogarth 1992 Expression of the high responder/non-responder human FcγRIIA. analysis by PCR and transfection into FcR-COS cells. Immunol. Cell. Biol. 70:79-87.
18. Parren, P.W.H.I., P.A.M. Warmerdam, L.C.M. Boeije, J. Arts, N.A.C. Westerdaal, A. Vlug, P.J.A Capel, L.A Aarden, and J.G J. van de Winkel. 1992. On the interaction of IgG subclasses with the low affinity FcγRIIA (CD32) on human monocytes, neutrophils, and platelets. Analysis of a functional polymorphism to human IgG2. J Clin. Invest 90:1537-1546.
19. Anderson, C L , L. Shen, D.M. Eicher, M.D. Wewer, and J.K. Gill. 1990. Phagocytosis mediated by three distinct Fcγ receptor classes on human leukocytes. J. Exp. Med. 171:1333-1345.
20. Indik, Z., C. Kelly, P. Chien, A.I. Levinson, and A.D. Schreiber. 1991 Human FcγRII, in the absence of other Fcγ receptors, mediates a phagocytic signal. J. Clin. Invest. 88:1766-1771
21. Wisnieski, J.J., and S.M. Jones. 1992. Comparison of autoantibodies to the collagen-like region of C1q in hypocomplementemic urticarial vasculitis syndrome and systemic lupus erythematosus. J. Immunol. 148:1396-1403.
22. Prada, A E., and C.F. Strife. 1992. IgG subclass restriction of autoantibody to solid-phase C1q in membranoproliferative and lupus glomerulonephritis. Clin. Immunol. Immunopathol 63 84-88
23. Hochberg, M.C. 1993. Epidemiology of systemic lupus erythematosus. Dubois' Lupus Erythematosus. J. Wallace and B H Hahn, editors. Lea & Febiger, Philadelphia 49-57.
24. Tan, E.M., A.S. Cohen, J.F. Fries, A.T. Masi, D.J. Mc Shane. N.F. Rothfield, J.G. Schaller, N. Talal, and R.J. Winchester 1982. The revised criteria for the classification of systemic lupus erythematosus. Arthritis & Rheum. 25:1271-1277.
25. Gosselin, E.J., M F. Brown, C.L. Anderson, T.F. Zipf, and P.M. Guyre 1990. The monoclonal antibody 41H16 detects the Leu 4 responder form of human FcγRII. J. Immunol. 144:1817-1822.
26. Osborne, J.M., G.W. Chacko, J.T. Brandt, and C.L. Anderson 1994. Ethnic variation in frequency of an allelic polymorphism of human FcγRIIA determined with allele specific oligonucleotide probes. J. Immunol Methods. 173:207-217.
27. Edberg, J.C., and R P. Kimberly. 1992. Receptor-specific probes for the study of Fcγ receptor specific function. J. Immunol. Methods. 148.179-187.
28. Hollander, M., and D.E. Wolfe. 1973. Nonparametric Statistical Methods. John Wiley & Sons, New York
29. Johnson, A.E , C. Gordon R.G Palmer, and P.A. Bacon 1994. The prevalence and incidence of systemic lupus erythematosus in Birmingham, England. Relationship to ethnicity and country of birth. Arthritis & Rheum. 38. 551-558.
30. Siegert, C., M. Daha, M.-L. Westedt, E. van der Voort. and F. Breedveld 1991 IgG autoantibodies against C1q are corrected with nephritis, hypocomplementemia, and dsDNA antibodies in systemic lupus erythematosus. J. Rheumatol. 18:230-234.
31. Uwatoko, S., and M. Mannik 1988. Low-molecular weight C1q-binding immunoglobulin G in patients with systemic lupus erythematosus consists of autoantibodies to collagen-like region of C1q. J Clin Invest 82:816-824.
32. Antes, U., H.-P. Heinz, and M. Loos. 1988. Evidence for the presence of autoantibodies to the collagen-like portion of C1q in systemic lupus erythematosus. Arthritis & Rheum. 31:457-464.
33. Siegert, C.E.H , M.R. Daha, A.J.G. Swaak, E.A.M. van der Voort, and F C. Breeveld. 1993. The relationship between the serum titers of autoantibodies to C1q and age in the general population and in patients with systemic lupus erythematosus Clin. Immunol. Immunopathol 67:204-209.
34. Wener, M H., M. Mannik, M M Schwartz, and E J. Lewis. 1987. The relationship between renal pathology and the size of circulating immune complexes in patients with systemic lupus erythematosus. Medicine (Baltimore.) 66: 85-97.
35. Uwatoko, S., V.J. Gauthier, and M. Mannik. 1991. Antibodies to the collagen-like region of C1q deposit in glomeruli via C1q in immune deposits Clin. Immunol. Immunopathol. 61:268-273.
36. Prada, A.E., and C.F. Strife. 1992. IgG subclass restriction of autoantibody to solid-phase C1q in membranoproliferative and lupus glomerulonephritis. Clin. Immunol Immunopathol. 63:84-88.
37. Moulds, J.M., M. Krych, V.M. Holers, K. Liszewski, and J.P. Atkinson. 1992. Genetics of the complement system and rheumatic disease. Rheum. Dis. Clin. 18:893-914.
38. Abo, T., A.B. Tilden, C.M. Balch, K. Kumagai, G M. Troup, and M.D. Cooper. 1984. Ethnic difference in the lymphocyte proliferation response induced by a murine IgG1 antibody, Leu-4, to the T3 molecule. J. Exp. Med. 160: 303-309
39. Dunckley, H., P.A. Gatenby, B. Hawkins, S. Naito, and S.W. Serjeantson. 1987. Deficiency of C4A is a genetic determinant of systemic lupus erythematosus in three ethnic groups. J. Immunogenet 14:209-218.
40. Hawkins, B.R , K L Wong, R.W. Wong, K H. Chan, H. Dunckley, and S.W. Serjeantson. 1987. Strong association between the major histocompatibility complex and systemic lupus erythematosus in southern Chinese. J. Rheumaiol. 14:1128-1131.
41. Yamada, H., A Wantanbe, A. Mimori, K. K. Nakano, F Takeuchi, K. Matsuta, K. Tanimoto, T. Miyamoto, Y. Yukiyama, K. Tokunaga, and R. Yokohari. 1990. A lack of gene deletion for complement C4A deficiency in Japanese patients with systemic lupus erythematosus. J. Rheumatol. 17:1054-1057.
42. Howard, P.F., M.C. Hochberg, WB. Bias, F C. Arnett, and R.H. McLean. 1986. Relationship between C4 null genes, HLA-D region antigens, and genetic susceptibility to systemic lupus erythematosus in Caucasians and Black Americans. Am. J. Med. 81:187-193.
43. Huang, D.-F., K.A. Siminovitch, X.-Y Liu, N.J. Olsen, C. Berry, D.A. Carson, and P P. Chen. 1995. Population and family studies of three disease-related polymorphic genes in systemic lupus erythematosus. J. Clin. Invest. 95: 1766-1772
44. McDaniel, D.O., G.S. Alarcon, P W. Pratt, and J.D. Reveille. 1995. Most African-Americans patients with rheumatoid arthritis do not have the rheumatoid antigenic determinant (epitope) Ann. Intern. Med. 123:181-187.
45. Blasini, A.M., I L. Stekman, M. Leon-Ponte, D Caldera, and M.A. Rodriquez. 1993. Increased proportion of responders to a murine anti-CD3 monoclonal antibody of the IgG1 class in patients with systemic lupus erythematosus. Clin. Exp. Immunol. 94:423-428.
46. Gmelig-Meyling, F.H.J , H. Bootsma, H.W.M. Derksen, P.E. Spronk, L. Kater, C.G.M Kallenberg, P.J.A. Capel, J.G.J. van de Winkel, and A.J. Duits. 1994. IgG Fc Receptor IIa (CD32) polymorphism in SLE: skewed allotype distribution among patients with renal disease. Arthritis & Rheum. 37:S167.
47. Drake, C.G., S.J. Rozzo, H.F. Hirschfeld, N.P. Smarnworawong, E. Palmer, and B.L. Kotzin. 1995. Analysis of the New Zealand Black contribution to lupus-like renal disease. Multiple genes that operate in a threshold manner. J. Immunol. 154:2441-2447.
48. Drake, C.G , S.K. Babcock, E. Palmer, and B.L. Kotzin. 1994. Genetic analysis of the NZB contribution to lupus-like autoimmune disease in (NZB × NZW)F1 mice. Proc. Natl. Acad Sci. USA. 91:4062-4066.
49. Morel, L., U.H. Rudofsky, J.A. Longmate, J. Schiffenbauer, and E.K Wakeland. 1994. Polygenic control of susceptibility to murine systemic lupus erythematosus. Immunity 1:219-229